相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy
C. M. Lange et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
New Lipoglycopeptides A Comparative Review of Dalbavancin, Oritavancin and Telavancin
George G. Zhanel et al.
DRUGS (2010)
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
Tara L. Kieffer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
PEG IFN alfa-2a vs. alfa-2b: And the winner is ... ?
Antonio Craxi
JOURNAL OF HEPATOLOGY (2010)
HCV drug discovery aimed at viral eradication
R. F. Schinazi et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Hepatitis C virus hijacks host lipid metabolism
Gulam H. Syed et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
Leen Delang et al.
VIRUSES-BASEL (2010)
Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors
Lotte Coelmont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antiviral activity of geneticin against dengue virus
Xianchao G. Zhang et al.
ANTIVIRAL RESEARCH (2009)
HCV NS5B Polymerase Inhibitors
James R. Burton et al.
CLINICS IN LIVER DISEASE (2009)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
Substituted imidazopyridines as potent inhibitors of HCV replication
Inge Vliegen et al.
JOURNAL OF HEPATOLOGY (2009)
Sequence variation of NS3 and NS4A in hepatitis C virus (HCV) replicons following exposure to ITMN-191 concentrations likely to encompass those achieved in human liver following clinical dosing
A. J. V. Thompson et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics
Arnoldo Riquelme et al.
LIVER INTERNATIONAL (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors
Jan Paeshuyse et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital
Aylin Acar Sancar et al.
PHARMACY WORLD & SCIENCE (2008)
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins
David Delgrange et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Persistent hepatitis C virus infection in vitro: Coevolution of virus and host
Jin Zhong et al.
JOURNAL OF VIROLOGY (2006)
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics
Jan Balzarini et al.
ANTIVIRAL RESEARCH (2006)
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse et al.
HEPATOLOGY (2006)
Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry
Maria N. Preobrazhenskaya et al.
ANTIVIRAL RESEARCH (2006)
Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin
SS Printsevskaya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Mixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulation
F Van Bambeke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex
D Moradpour et al.
ANTIVIRAL RESEARCH (2003)
Antiretroviral activity of semisynthetic derivatives of glycopeptide antibiotics
J Balzarini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose
F Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Glycopeptide derivatives
A Malabarba et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies
DL Boger
MEDICINAL RESEARCH REVIEWS (2001)
Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form
KE Anderson et al.
PHARMACEUTICAL RESEARCH (2001)
分享论文
